Microangiopathic lesions associated with poor immunosuppressive therapy response in IgA nephropathy

Clicks: 16
ID: 332450
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #119 of 152 articles by views in nephrology dialysis transplantation

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 152 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background and Hypothesis Renal arteriolar microangiopathic lesions are frequently observed in immunoglobulin A nephropathy (IgAN). However, their impact on the response to immunosuppressive therapy remains unclear. This study aimed to evaluate the association between these lesions and treatment response in patients with IgAN. Methods In this prospective cohort study, we included 620 patients with biopsy-proven primary IgAN who had persistent proteinuria ≥1 g/d despite at least 3 months of optimized supportive care with renin-angiotensin system inhibitors (RASi) and subsequently received immunosuppressive therapy for >6 months. Renal arteriolar microangiopathic lesions were independently reviewed by two pathologists. The primary outcome was treatment response, defined as a ≥50% reduction in proteinuria from baseline to <1 g/day, combined with an estimated glomerular filtration rate (eGFR) decline of <25%. Logistic regression, propensity score matching (PSM), and subgroup analyses were used to assess the association between microangiopathic lesions and treatment response. Results Among the 620 enrolled patients, 154 (24.8%) had renal arteriolar microangiopathic lesions. Compared to patients without microangiopathic lesions, those with microangiopathic lesions had higher blood pressure, more severe proteinuria, and lower eGFR. The non-response rate to immunosuppressive therapy was significantly higher in patients with microangiopathic lesions than in those without (61.0% vs. 26.2%). Multivariable logistic regression indicated that the presence of microangiopathic lesions was independently associated with an increased risk of non-response (odds ratio 4.04, 95% confidence interval 2.61-6.25). This association remained consistent after PSM and across all prespecified subgroups. Conclusion Renal arteriolar microangiopathic lesions are relatively common in IgAN and are associated with worse clinical outcomes and poorer response to immunosuppressive therapy. These findings suggest that conventional immunosuppression may be less effective for this high-risk subgroup, necessitating further research into targeted therapeutic strategies.
Reference Key
openalex_W7222253207 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal nephrology dialysis transplantation
Year 2026
DOI
10.1093/ndt/gfag237
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.